Dec 20, 2021
Merck Acquires Chord Therapeutics to Expand Neuroinflammatory Pipeline
Read now
Oct 22, 2020
Spotlight on rare NMOSD: Chord launches with $16m Series A round
Read now
Oct 15, 2020
Chord Therapeutics in the media
Read now
Oct 13, 2020
Chord Therapeutics launches with USD 16 million Series A financing from Omega Funds
Read now
Oct 13, 2020
Chord Therapeutics: New oral treatments for NMOSD & myasthenia gravis
Read now
